MedTrace Logo

Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms

NCT05225038 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2024-09-19

No results posted yet for this study

Summary

Randomized Clinical Trial Investigating Multidimensional Prehabilitation in Pancreatic Surgery for participants with Pancreatic and Periampullary Neoplasms

Conditions

  • Pancreatic Neoplasms
  • Periampullary Carcinoma

Interventions

OTHER

Exercise

Participants will meet with an exercise physiologist to undergo evaluation and develop individualized regimens for prehabilitation.

DIETARY_SUPPLEMENT

Nutritional

Participants will meet with a nutritionist to undergo evaluation and develop individualized regimens for prehabilitation.

BEHAVIORAL

Behavioral Medicine

Participants will have 1 appointment with behavioral medicine - all participants will meet with the same behavioral medicine specialist to ensure consistency. Participants will receive education regarding factors that affect postoperative recovery and relaxation techniques. Participants will also have the option to request faith support.

BEHAVIORAL

Smoking Cessation

Participants who are actively smoking will be counseled regarding smoking cessation during their preoperative appointment with a member of the surgical team. They will also be offered a referral to smoking cessation resources.

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-13
Primary Completion
2023-10-30
Completion
2023-10-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05225038 on ClinicalTrials.gov